Dollie F Green, MD | |
1611 Nw 12th Ave, Box 016960 M851, Miami, FL 33136-1005 | |
(305) 585-1111 | |
Not Available |
Full Name | Dollie F Green |
---|---|
Gender | Female |
Speciality | Nephrology |
Experience | 43 Years |
Location | 1611 Nw 12th Ave, Miami, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295763175 | NPI | - | NPPES |
0458091-00 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | ME50348 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida International University Board Of Trustees | 3072777150 | 19 |
News Archive
OrphageniX Inc., a new biotechnology company founded by University of Delaware researchers, has been established in Wilmington to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy.
Researchers at Massachusetts Institute of Technology (MIT) have potentially found a way to eliminate some of the endoscopic surgeries need to remove gastrointestinal (GI) medical devices.
Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.
At the Healthcare Information and Management Systems Society's 2015 conference (HIMSS15), Elekta will introduce Elekta Healthcare Analytics, a solution for accelerating data analysis to improve clinical, operational and financial decision making.
› Verified 3 days ago
Entity Name | Florida International University Board Of Trustees |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598070849 PECOS PAC ID: 3072777150 Enrollment ID: O20120621000541 |
News Archive
OrphageniX Inc., a new biotechnology company founded by University of Delaware researchers, has been established in Wilmington to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy.
Researchers at Massachusetts Institute of Technology (MIT) have potentially found a way to eliminate some of the endoscopic surgeries need to remove gastrointestinal (GI) medical devices.
Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.
At the Healthcare Information and Management Systems Society's 2015 conference (HIMSS15), Elekta will introduce Elekta Healthcare Analytics, a solution for accelerating data analysis to improve clinical, operational and financial decision making.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dollie F Green, MD 1500 Nw 12th Ave, Jmt-east 1007, Miami, FL 33136-1028 Ph: (305) 243-4664 | Dollie F Green, MD 1611 Nw 12th Ave, Box 016960 M851, Miami, FL 33136-1005 Ph: (305) 585-1111 |
News Archive
OrphageniX Inc., a new biotechnology company founded by University of Delaware researchers, has been established in Wilmington to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy.
Researchers at Massachusetts Institute of Technology (MIT) have potentially found a way to eliminate some of the endoscopic surgeries need to remove gastrointestinal (GI) medical devices.
Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.
At the Healthcare Information and Management Systems Society's 2015 conference (HIMSS15), Elekta will introduce Elekta Healthcare Analytics, a solution for accelerating data analysis to improve clinical, operational and financial decision making.
› Verified 3 days ago
Dr. Rhea Bettina Sancassani, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1801 Nw 9th Ave Ste 209, Miami, FL 33136 Phone: 786-466-8490 Fax: 305-573-6562 | |
Mrs. Dania M Verdecia, ARNP Nephrology Medicare: Accepting Medicare Assignments Practice Location: 11880 Bird Road, Suit 411, Miami, FL 33175 Phone: 305-223-1959 Fax: 305-220-7102 | |
Jacklyn Reyes Pancrudo, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 11750 Sw 40th St, Miami, FL 33175 Phone: 561-997-0821 | |
Ms. Madeline De Los Milagros Castro, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 971 Nw 2nd St, Miami, FL 33128 Phone: 305-545-7737 | |
Irwin Singer, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1201 Nw 16th St, Miami, FL 33125 Phone: 305-575-3160 | |
Dr. Manrique Oscar Iriarte, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 12750 Nw 17th St, Miami, FL 33182 Phone: 305-781-4815 | |
Dr. Gianluca Iacobellis, M.D. PH.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1450 Nw 10th Ave, Miami, FL 33136 Phone: 305-243-3636 Fax: 305-243-6575 |